Ivo Abraham Selected Research

Valsartan (Vals)

1/2021	Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients.
1/2017	Hierarchical Modeling of Patient and Physician Determinants of Blood Pressure Outcomes in Hypertensive Patients with and without Diabetes: Pooled Analysis of Six Observational Valsartan Studies with 15,282 Evaluable Patients.
1/2011	Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program.
5/2009	Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivo Abraham Research Topics

Disease

34	Neoplasms (Cancer) 10/2023 - 01/2008
15	Chemotherapy-Induced Febrile Neutropenia 11/2022 - 03/2011
13	Febrile Neutropenia 11/2022 - 03/2011
9	Neutropenia 06/2022 - 01/2017
9	Anemia 04/2022 - 01/2008
8	COVID-19 04/2023 - 01/2021
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 10/2019
7	Breast Neoplasms (Breast Cancer) 05/2023 - 11/2015
7	Melanoma (Melanoma, Malignant) 01/2023 - 01/2016
7	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021 - 01/2017
6	Hypertension (High Blood Pressure) 01/2021 - 05/2009
5	Pain (Aches) 10/2023 - 02/2022
5	Asthma (Bronchial Asthma) 01/2023 - 09/2017
4	Cognitive Dysfunction 10/2023 - 01/2020
4	Multiple Myeloma 01/2023 - 03/2011
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2021 - 05/2009
4	Lymphoma (Lymphomas) 09/2021 - 11/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2011
3	Spinal Stenosis (Stenosis, Spinal) 04/2024 - 02/2022
3	Fatigue 10/2023 - 01/2017
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 08/2021
3	Thrombocytopenia (Thrombopenia) 04/2022 - 12/2016
3	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 01/2013
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2017 - 06/2011
2	Chronic Urticaria 10/2022 - 01/2019
2	Lung Neoplasms (Lung Cancer) 06/2022 - 01/2020
2	Intervertebral Disc Displacement (Herniated Disc) 04/2022 - 02/2022
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 04/2022 - 11/2021
2	Infections 01/2022 - 01/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2021 - 01/2021
2	Hypothyroidism 04/2021 - 01/2020
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2020
2	Colitis 01/2021 - 01/2020
2	Critical Illness (Critically Ill) 01/2021 - 10/2020
2	Diarrhea 01/2020 - 01/2017
2	Prostatic Neoplasms (Prostate Cancer) 11/2019 - 02/2019
2	Adenocarcinoma 10/2019 - 04/2017
2	Type 2 Diabetes Mellitus (MODY) 06/2019 - 12/2016
2	Hematologic Neoplasms (Hematological Malignancy) 03/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 03/2019 - 11/2018
2	Urticaria (Hives) 01/2019 - 01/2018

Drug/Important Bio-Agent (IBA)

26	Biosimilar PharmaceuticalsIBA 01/2023 - 03/2011
15	Filgrastim (Neupogen)FDA Link 01/2023 - 03/2011
14	pegfilgrastim (Neulasta)FDA Link 11/2022 - 06/2012
7	Omalizumab (Xolair)FDA Link 01/2023 - 09/2017
7	osimertinibIBA 11/2020 - 11/2020
6	Gemcitabine FDA Link 01/2024 - 01/2017
6	pembrolizumabIBA 01/2024 - 10/2019
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 03/2011
6	IpilimumabIBA 12/2021 - 01/2016
5	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2016
5	HematinicsIBA 04/2013 - 02/2008
4	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 12/2016
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 01/2020
4	Imatinib Mesylate (Gleevec)FDA Link 12/2021 - 05/2009
4	130-nm albumin-bound paclitaxelIBA 11/2021 - 04/2017
4	Rituximab (Mabthera)FDA Link 11/2021 - 04/2015
4	folfirinoxIBA 11/2021 - 04/2017
4	NivolumabIBA 04/2021 - 10/2019
4	Valsartan (Vals)FDA Link 01/2021 - 05/2009
4	Ranibizumab (Lucentis)FDA Link 01/2020 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 10/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2020
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 04/2015
3	Prednisone (Sone)FDA LinkGeneric 09/2021 - 11/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2021 - 01/2017
3	Epoetin Alfa (Epogen)FDA Link 01/2018 - 01/2014
3	IronIBA 01/2017 - 06/2011
2	AlbuminsIBA 12/2023 - 01/2019
2	CytokinesIBA 10/2023 - 12/2019
2	favipiravirIBA 04/2023 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 12/2019
2	Monoclonal AntibodiesIBA 01/2023 - 01/2019
2	ibrutinibIBA 04/2022 - 01/2017
2	trilaciclibIBA 04/2022 - 11/2021
2	Docetaxel (Taxotere)FDA Link 01/2022 - 11/2019
2	AnticoagulantsIBA 01/2022 - 12/2016
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 07/2019
2	talimogene laherparepvecIBA 12/2021 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 11/2021 - 05/2018
2	Bendamustine Hydrochloride FDA Link 11/2021 - 08/2021
2	Vincristine (Oncovin)FDA LinkGeneric 09/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 06/2021 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 07/2019
2	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 09/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 03/2020 - 05/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2019 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 06/2019 - 12/2016
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 06/2019 - 06/2012
2	VildagliptinIBA 06/2019 - 12/2016
2	Phosphates (Orthophosphate)IBA 01/2019 - 12/2014
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2018 - 10/2018

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 05/2023 - 01/2008
31	Therapeutics 06/2023 - 10/2007
4	Decompression 04/2024 - 02/2022
2	Drug Tapering 11/2022 - 03/2019
2	Artificial Respiration (Mechanical Ventilation) 05/2022 - 01/2013
2	Critical Care (Surgical Intensive Care) 05/2022 - 01/2022